Pediatric Dermatology最新文献_第2页

Is It Hepatotoxicity? Isolated AST Elevation During Isotretinoin Therapy in an Adolescent. 是肝毒性吗？一名青少年异维甲酸治疗期间孤立性AST升高。

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-27 DOI: 10.1111/pde.70348

Varshita Chirumamilla, Rachel E Tao, Leah Lalor, Alexis J Gumm

引用次数: 0

Acute Pustular Facial Eruption in a 5-Year-Old Boy. 1例5岁男童面部急性脓疱性爆发。

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-24 DOI: 10.1111/pde.70331

Naia Oillarburu, Magalie Coco-Viloin, Emilie Tournier, Juliette Mazereeuw-Hautier, Maella Severino-Freire

引用次数: 0

Growth Assessment in Children Under 12 Years With Moderate-to-Severe Atopic Dermatitis Included in the PEDISTAD Observational Registry. 12岁以下中重度特应性皮炎儿童的生长评估纳入PEDISTAD观察登记。

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-18 DOI: 10.1111/pde.70335

Amy S Paller, Alan D Irvine, Eulalia Baselga, Marlies de Graaf, Elaine C Siegfried, Michael J Cork, Michele Ramien, Lawrence F Eichenfield, Bryan Adams, Rajan Gupta, Marius Ardeleanu, Annie Zhang

{"title":"Growth Assessment in Children Under 12 Years With Moderate-to-Severe Atopic Dermatitis Included in the PEDISTAD Observational Registry.","authors":"Amy S Paller, Alan D Irvine, Eulalia Baselga, Marlies de Graaf, Elaine C Siegfried, Michael J Cork, Michele Ramien, Lawrence F Eichenfield, Bryan Adams, Rajan Gupta, Marius Ardeleanu, Annie Zhang","doi":"10.1111/pde.70335","DOIUrl":"https://doi.org/10.1111/pde.70335","url":null,"abstract":"Background/objective: The multifactorial disease burden of moderate-to-severe atopic dermatitis (AD) may affect children's growth. We report height, weight, and body mass index (BMI) of children under 12 years old with moderate-to-severe AD in comparison to the general population.Methods: This was a cross-sectional analysis of enrollment data from PEDISTAD, a global real-world observational study of pediatric patients < 12 years old with moderate-to-severe AD.Results: Among the 1329 children with moderate-to-severe AD, 72% of male children 5 to < 12 years were below the 50th percentile for height, as were 53% of females in this age group. In contrast, the weight of children 5 to < 12 years was above the 50th percentile in 56% of males and 52% of females, resulting in above-average BMI values. In the 0 to < 5 years old age groups, height and weight were above the 50th percentile for 59% and 50% of female children, and 52% and 42% of male children, respectively.Conclusions: This real-world observational study showed in children 5 to < 12 years old with moderate-to-severe AD that the average height was lower than the US 50th percentile, with a more pronounced reduction in male children. Additionally, higher weight and, as a result, higher BMI were observed in the children included in this analysis.Trial registration: ClinicalTrials.gov identifier: NCT03687359.","PeriodicalId":19819,"journal":{"name":"Pediatric Dermatology","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148796498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hepatitis B Immunity in Children on Immunomodulators: Implications From a Pediatric Dermatology Cohort and Review of the Literature. 免疫调节剂对儿童乙型肝炎免疫的影响：来自儿童皮肤病学队列和文献综述的意义

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-18 DOI: 10.1111/pde.70337

Adrienne Conza, Racquel A Bitar, Fiona H Lynch, Pierre-Olivier Grenier, Elena B Hawryluk, Sarah E Servattalab

{"title":"Hepatitis B Immunity in Children on Immunomodulators: Implications From a Pediatric Dermatology Cohort and Review of the Literature.","authors":"Adrienne Conza, Racquel A Bitar, Fiona H Lynch, Pierre-Olivier Grenier, Elena B Hawryluk, Sarah E Servattalab","doi":"10.1111/pde.70337","DOIUrl":"https://doi.org/10.1111/pde.70337","url":null,"abstract":"Background/objectives: This study aims to determine the level of hepatitis B virus (HBV) immunity in patients who had HBV serologic testing prior to starting immunomodulatory medication for dermatologic conditions at a single institution and to review evidence on waning immunity, serologic interpretation, and revaccination.Methods: We performed a retrospective chart review of pediatric and young adult patients initiated on immunomodulatory therapy for dermatologic conditions who had HBV serologic testing prior to initiation. A focused literature review was conducted on durability of HBV immunity, HBV serologies in the context of immunomodulatory medications, and revaccination recommendations.Results: In this cohort of 23 children, roughly 40% lacked HBV serologic immunity. Prior studies demonstrated that antibody-mediated protection is heterogeneous and anti-HBs titers decline over time. Existing guidelines are largely derived from adult populations. Evidence regarding revaccination strategies is mixed. Notably, absence of detectable anti-HBs antibodies does not always equate to loss of immune memory or susceptibility to infection.Conclusions: Anti-HBs titers are variable and wane over time. Experts agree that patients should receive all recommended vaccinations before starting immunomodulatory therapy and be screened for HBV beforehand, based on adult guidelines. It is uncertain how well these recommendations apply to children, who generally have lower HBV risk and prevalence. Guidance is needed on how to manage pediatric patients without serologic evidence of HBV immunity before beginning biologic treatments.","PeriodicalId":19819,"journal":{"name":"Pediatric Dermatology","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148796512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Much Ado About a Mutation: Congenital Melanocytic Nevus With LINC00518 and Preferentially Expressed Antigen in Melanoma Positivity. 突变：先天性黑素细胞痣与LINC00518和黑色素瘤阳性优先表达抗原。

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-17 DOI: 10.1111/pde.70341

Racquel A Bitar, Tatiana F Abrantes, Holly Neale, Birgitta A R Schmidt, Ingrid M Ganske, Elena B Hawryluk

引用次数: 0

Staphylococcal Scalded Skin Syndrome Often Does Not Require Empiric Coverage for Methicillin Resistance. 葡萄球菌烫伤皮肤综合征通常不需要甲氧西林耐药性的经验覆盖。

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-06 DOI: 10.1111/pde.70279

Katharina W Horn, Jessica S Hathaway, Jason E Zucker, Maria C Garzon, Brandon T Cunnane, Kimberly D Morel, Laura E Levin, Gregory J Berry, Christine T Lauren

引用次数: 0

Oral Sirolimus Treatment for HRAS-Related Epidermal Nevus Syndrome. 口服西罗莫司治疗hras相关表皮痣综合征。

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-06 DOI: 10.1111/pde.70339

Moira Shea, Milie M Fang, Liza Kenny, Melinda D Wu, Tracy Funk

引用次数: 0

DTaP-IPV Vaccination-Induced Granuloma Diagnosed With Multi-Virus/Microbial Real-Time PCR. 多病毒/微生物实时荧光定量PCR诊断DTaP-IPV疫苗诱导肉芽肿

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-06 DOI: 10.1111/pde.70333

Hiroshi Hayashi, Yuto Otsubo, Kentaro Matsuoka, Yuho Horikoshi, Harutaka Katano, Yuki Yuza

引用次数: 0

Association Between Infantile Atopic Dermatitis and Mother-to-Infant Bonding Disorder: A Cross-Sectional Study. 婴儿特应性皮炎与母婴结合障碍之间的关系：一项横断面研究。

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-04 DOI: 10.1111/pde.70312

Sawako Kamo, Takahiro Tabuchi, Daisuke Nishi

{"title":"Association Between Infantile Atopic Dermatitis and Mother-to-Infant Bonding Disorder: A Cross-Sectional Study.","authors":"Sawako Kamo, Takahiro Tabuchi, Daisuke Nishi","doi":"10.1111/pde.70312","DOIUrl":"https://doi.org/10.1111/pde.70312","url":null,"abstract":"Background/objectives: Mother-to-infant bonding disorder (MIBD) can hugely impact the relationship between mothers and infants, maternal mental health, and child development. Although infantile atopic dermatitis (AD) is known to influence caregivers' quality of life and mental health, its effect on MIBD is not fully understood. This study examined the association between MIBD and infantile AD using data from 4236 postpartum women from a cross-sectional nationwide survey: the Japan COVID-19 and Society Internet Survey (JACSIS).Methods: We assessed MIBD using the Japanese version of the Mother-to-Infant Bonding Scale (MIBS-J), the presence of infantile AD based on maternal perception (reported AD: R-AD) and physician's diagnosis (diagnosed-AD: D-AD), and participants' demographics. To assess the association between MIBD and infantile AD, we conducted a modified Poisson regression with robust error variance that provided relative risks (RRs) and 95% confidence intervals (CIs).Results: The prevalence of MIBD was about 24.2% (n = 1024). Whether infantile AD was R-AD (RR = 1.22, 95% CI: 1.07-1.40) or D-AD (RR = 1.41, 95% CI: 1.18-1.69), its presence was significantly associated with a higher RR for MIBD. Furthermore, we found that infantile AD was associated with a higher RR for Anger and Rejection, a subscale of the MIBS-J.Conclusions: This study showed that infantile AD is a potential risk factor for MIBD. Further studies should investigate the link between infantile AD and MIBD and determine effective support for mothers and infants with AD.","PeriodicalId":19819,"journal":{"name":"Pediatric Dermatology","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148674063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Chasing Ghosts in Pediatric Dermatology: Provider-Directory Inaccuracy and Medicaid Access for Children With Skin Disease. 追逐儿童皮肤病学中的幽灵：提供者目录的不准确性和儿童皮肤病的医疗补助。

IF 1.2 4区医学

Pediatric Dermatology Pub Date : 2026-08-04 DOI: 10.1111/pde.70329

Martha-Grace McLean

引用次数: 0